Skip to content
Featured ButtonFraud Hotline
aging_rs_banner

Majority Press

 Expand
Skip to page number selection

Press releases from: March 2026

Published
Chairman Rick Scott Announces Senior Citizens’ Freedom to Work Act at Hearing on Seniors in the Workforce
Published
El presidente del Comité Scott y la miembro de alto rango Gillibrand anuncian una audiencia que destaca el papel de los estadounidenses mayores en la fuerza laboral estadounidense
Published
Chairman Scott, Ranking Member Gillibrand Announce Hearing Highlighting Aging Americans’ Role in the U.S. Workforce
Published
IN CASE YOU MISSED IT… Chairman Scott, Ranking Member Gillibrand Push CLEAR LABELS Act to Label Foreign-Made Drugs
Published
IN CASE YOU MISSED IT… Chairman Scott, Ranking Member Gillibrand Highlight CLEAR LABELS Act in ABC News Interview on Securing U.S. Drug Supply Chain
Published
El presidente del Comité Rick Scott expone el peligroso control de la China comunista sobre el suministro de medicinas de Estados Unidos; Destaca la Ley de CLEAR LABELS para aumentar la transparencia
Published
Chairman Rick Scott Exposes Communist China’s Dangerous Grip on America’s Medicine Supply; Highlights CLEAR LABELS Act to Increase Transparency
Published
Chairman Scott, Ranking Member Gillibrand Set Hearing to Expose China’s Control of America’s Drug Supply
Published
El presidente del Comité Scott y la miembro de alto rango Gillibrand fijan audiencia para exponer el control de China en el suministro de drogas estadounidense
Published
Chairman Rick Scott, Sen. Mark Kelly Lead Bipartisan Resolution Designating March 5th as National Slam the Scam Day
Published
Chairman Rick Scott’s CLEAR LABELS Act Garners Bicameral Support with Rep. McCormick in the U.S. House
Published
Chairman Scott, Ranking Member Gillibrand Press America’s Pharmacies on U.S. Drug Supply Chain and Country-of-Origin Labeling for Foreign-Made Drugs

Press releases from: February 2026

Published
El presidente del Comité Rick Scott aborda los obstáculos regulatorios que retrasan los tratamientos de enfermedades raras y limitan el acceso de los pacientes a la innovación
Published
Chairman Rick Scott Addresses Regulatory Hurdles Delaying Rare Disease Treatments and Limiting Patient Access to Innovation
Published
El presidente del Comité Scott y la miembro de alto rango Gillibrand examinarán los procesos regulatorios de la FDA, los retrasos en el tratamiento de enfermedades raras y la necesidad de mejorar el acceso de los pacientes a la innovación
Published
Chairman Scott, Ranking Member Gillibrand to Examine FDA Regulatory Processes, Rare Disease Treatment Delays, and the Need to Improve Patient Access to Innovation
Published
Chairman Rick Scott Sends Letter to Secretary Hegseth on Securing Generic Drug Supply for Service Members and Veterans
Published
Chairman Rick Scott to Convene Hearing on FDA Regulatory Processes, Rare Disease Treatment Delays, and Opportunities to Improve Patient Access to Innovation
Published
El presidente del Comité Rick Scott expone cómo la burocracia de Washington está perjudicando a los pacientes y socavando la sanidad
Published
Chairman Rick Scott Exposes How Washington’s Red Tape is Harming Patients, Undermining Health Care